Kenneth Fong is Founder and Chairman of Kenson Ventures, a venture capital firm that provides funds and strategic advice to biotechnology start-ups and companies. Prior to Kenson, he founded Clontech Laboratories in 1984, a molecular biology company that grew to 400 employees and posted revenues of $80 million dollars before merging with Becton Dickinson in 1999. Born in China, Ken received a bachelor’s degree in biology and chemistry at San Francisco State University, five years after emigrating from Hong Kong. He went on to earn a Ph.D. in molecular biology at Indiana University. Today, he nurtures the emerging biotechnology field here and in Asia by serving on non-profit and university boards and government-sponsored institutes. President, Kenson Ventures, LLC (2000- ) Founder and CEO, Clontech Laboratories (1984-1999) B.S. in biology, San Francisco State University (1971) Ph.D. in molecular biology and microbiology, Indiana University (1977)